GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cell Biotech Co Ltd (XKRX:049960) » Definitions » EV-to-Revenue

Cell Biotech Co (XKRX:049960) EV-to-Revenue : 0.22 (As of May. 27, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Cell Biotech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cell Biotech Co's enterprise value is ₩11,831 Mil. Cell Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩53,980 Mil. Therefore, Cell Biotech Co's EV-to-Revenue for today is 0.22.

The historical rank and industry rank for Cell Biotech Co's EV-to-Revenue or its related term are showing as below:

XKRX:049960' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.12   Med: 2.87   Max: 12.76
Current: 0.22

During the past 13 years, the highest EV-to-Revenue of Cell Biotech Co was 12.76. The lowest was 0.12. And the median was 2.87.

XKRX:049960's EV-to-Revenue is ranked better than
91.91% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs XKRX:049960: 0.22

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Cell Biotech Co's stock price is ₩12010.00. Cell Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩7,888.57. Therefore, Cell Biotech Co's PS Ratio for today is 1.52.


Cell Biotech Co EV-to-Revenue Historical Data

The historical data trend for Cell Biotech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Biotech Co EV-to-Revenue Chart

Cell Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 2.47 1.63 0.45 0.15

Cell Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.53 0.19 0.15 0.17

Competitive Comparison of Cell Biotech Co's EV-to-Revenue

For the Biotechnology subindustry, Cell Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Biotech Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cell Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cell Biotech Co's EV-to-Revenue falls into.



Cell Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cell Biotech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=11831.288/53980.365
=0.22

Cell Biotech Co's current Enterprise Value is ₩11,831 Mil.
Cell Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩53,980 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cell Biotech Co  (XKRX:049960) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cell Biotech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=12010.00/7888.57
=1.52

Cell Biotech Co's share price for today is ₩12010.00.
Cell Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,888.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cell Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cell Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Biotech Co (XKRX:049960) Business Description

Traded in Other Exchanges
N/A
Address
134 Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-Do, KOR, 415-872
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Cell Biotech Co (XKRX:049960) Headlines

No Headlines